Pune, India -- (SBWIRE) -- 11/12/2018 -- The report is a comprehensive presentation of trends, forecast and dollar values of Global translational Regenerative Medicine Market. According to report the global translational regenerative medicine market is growing with a CAGR of 34.78 % from 2017 to 2023. Moreover, the global translational regenerative medicine market size was totaled 11.87 billion in 2016 and it is estimated to reach USD 52.94 billion by the end of 2023. The North America region accounted for the largest market share of approximate 51% in 2016 and is expected to remain dominant through the forecast period. The Asia-Pacific region is expected to grow at highest CAGR of 22.66% during the forecast period.

Make an Inquiry for Purchasing this Premium Report @ https://www.infiniumglobalresearch.com/reports/enquiry/302

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology. Regenerative medicines deal with the process of engineering & replacing human cells, tissues or organs to restore or establish normal function. Regenerative medicines primarily help to restore structure and function of damaged tissues and organs by stimulating body's own repair mechanism. These medicines are used in wide range of degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications.

Rising awareness among people regarding regenerative medicines, increasing government initiative across the globe and growing aging population & healthcare expenditure are considered to be the key factors driving the growth of global translational regenerative medicine market. However, higher cost of research and development and complex government approval processes are major restraints for global regenerative medicine market. Increase in adoption of regenerative medicines and growth in aging population expected to bring new opportunities for growth over the forecast period.

North America is the largest market for regenerative medicines and accounted highest market shares as of 2015. High medical reimbursement facilities and technological advancement in the region are considered to be the key factors driving the dominance of North America in global regenerative medicines market.

For More Details Get FREE Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/302

Major Key Players mentioned in this Premium Report

The report provides profiles of the companies in the global translational regenerative medicine market such as, Anika Therapeutics, Nuvasive, Inc., Orthofix International N.V, MEDIPOST, Athersys, Inc., Celgene Corporation, Vericel Corporation, Novartis, Brainstorm Cell Therapeutics Inc. and Gamida Cell Ltd.